SEARCH

SEARCH BY CITATION

References

  • Ara J., Przedborski S., Naini A. B., Jackson-Lewis V., Trifiletti R. R., Horwitz J. & Ischiropoulos H. (1998) Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl Acad. Sci. USA 95, 76597663.DOI: 10.1073/pnas.95.13.7659
  • Beckman J. S., Ye Y. Z., Andeson P. G., Chen J., Accavitti M. A., Tarpey M. M. & White C. R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe–Seyler 375, 8188.
  • Chen C. A. & Okayama H. (1997) High-efficient transfection using calcium phosphate using calcium phosphate-DNA precipitate formed in BES, in Current Protocols in Molecular Biology ( AusubelF. M., BrentR., KingstonR. E., MooreD. D., SeidmanJ. G., SmithJ. A. and StruhlK., eds), pp. 917919. John Wiley & Sons, New York.
  • Conway K. A., Harper J. D. & Lansbury P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 13181320.DOI: 10.1038/3311
  • Cuzzocrea S., Misko T. P., Costantino G., Mazzon E., Micali A., Caputi A. P., Macarthur H. & Salvemini D. (2000) Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 14, 10611072.
  • Duda J. E., Giasson B. I., Chen Q., Gur T. L., Hurting H. I., Stern M. B., Collomp S. M., Ischiropoulos H., Lee V. M.-Y. & Trojanowski J. Q. (2000a) Widspread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am. J. Pathol 157, 14391445.
  • Duda J. E., Giasson B. I., Gur T. L., Montine T. J., Robertson D., Biaggioni I., Hurtig H. I., Stern M. B., Gollomp S. M., Grossman M., Lee V. M.-Y. & Trojanowski J. Q. (2000b) Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy. J. Neuropath. Exp. Neurol. 59, 830841.
  • El-Agnaf O. M., Jakes R., Curran M. D. & Wallace A. (1998) Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440, 6770.DOI: 10.1016/s0014-5793(98)01419-7
  • Engelender S., Kaminsky Z., Guo X., Sharp A. H., Amaravi R. K., Kleiderlein J. J., Margolis R. L., Troncoso J. C., Lanahan A. A., Worley P. F., Dawson V. L., Dawson T. M. & Ross C. A. (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22, 110114.
  • Fahn S. & Przedborski S. (2000) Parkinsonism, in Merritt's Neurology ( RowlandL. P., ed. ), pp. 679693. Lippincott Williams & Wilkins, New York.
  • Galvin J. E., Giasson B., Hurtig H. I. & Lee V. M.-Y. (2000) Neurodegeneration with brain iron accumulation type 1 is characterized by α, β, and γ-synuclein neuropathology. Am. J. Pathol. 157, 361368.
  • Giasson B. I., Uryu K., Trojanowski J. Q. & Lee V. M. (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274, 76197622.
  • Giasson B. I., Duda J. E., Murray I., Chen Q., Souza J. M., Hurting H. I., Ischiropoulos H., Trojanowski J. Q. & Lee V. M.-Y. (2000a) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290, 985989.
  • Giasson B. I., Jakes R., Goedert M., Duda J. E., Leight S., Trojanowski J. Q. & Lee V. M.-Y. (2000b) A panel of epitope-specific antibodies detects throughout human α-synuclein in Lewy bodies of Parkinson's disease. J. Neurosci. Res. 59, 528533.DOI: 10.1002/(sici)1097-4547(20000215)59:4<528::aid-jnr8>3.3.co;2-s
  • Golbe L. I. (1999) Alpha-synuclein and Parkinson's disease. Mov. Disord. 14, 69.
  • Ischiropoulos H. (1998) Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356, 111.DOI: 10.1006/abbi.1998.0755
  • Ischiropoulos H. & Al Mehdi A. B. (1995) Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364, 279282.DOI: 10.1016/0014-5793(95)00307-u
  • Jakes R., Spillantini M. G. & Goedert M. (1994) Identification of two distinct synuclein from human brains. FEBS Lett. 345, 2732.
  • Mandir A. S., Przedborski S., Jackson-Lewis V., Wang Z. Q., Simbulan-Rosenthal M., Smulson M. E., Hoffman B. E., Guastella D. B., Dawson V. L. & Dawson T. M. (1999) Poly (ADP-ribose) polymerase activation mediates MPTP-induced parkinsonism. Proc. Natl Acad. Sci. USA 96, 57745779.DOI: 10.1073/pnas.96.10.5774
  • Narhi L., Wood S. J., Steavenson S., Jiang Y., Wu G. M., Anafi D., Kaufman S. A., Martin F., Sitney K., Denis P., Louis J. C., Wypych J., Biere A. L. & Citron M. (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274, 98439846.
  • Pennathur S., Jackson-Lewis V., Przedborski S. & Heinecke J. W. (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and O,O′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 274, 3462134628.
  • Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I. & Nussbaum R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 20452047.DOI: 10.1126/science.276.5321.2045
  • Pong K., Doctrow S. R. & Baudry M. (2000) Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine- induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons. Brain Res. 881, 182189.
  • Przedborski S. & Jackson-Lewis V. (2000) ROS and Parkinson's disease: a view to a kill, in Free Rdicals in Brain Pathophysiology ( PoliG., CadenasE. and PackerL., eds), pp. 273290. Marcel Dekker Inc., New York.
  • Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. & Dawson T. M. (1996) Role of neuronal nitric oxide in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 45654571.DOI: 10.1073/pnas.93.10.4565
  • Przedborski S., Jackson-Lewis V., Djaldetti R., Liberatore G., Vila M., Vukosavic S. & Almer G. (2000a) The parkinsonian toxin MPTP: action and mechanism. Restor. Neurol. Neurosci. 16, 135142.
  • Przedborski S., Jackson-Lewis V., Naini A., Jakowec M., Petzinger G., Miller R. & Akram M. (2000b) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. in press.
  • Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E. & Beal M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936939.
  • Souza J. M., Giasson B. I., Chen Q., Lee V. M. & Ischiropoulos H. (2000) Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275, 1834418349.
  • Spillantini M. G., Schmidt M. L., Lee V. M.-Y., Trojanowski J. Q., Roos J. & Goedert M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839840.DOI: 10.1038/42166
  • Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M. & Goedert M. (1998) α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 64696473.DOI: 10.1073/pnas.95.11.6469
  • Ye Y. Z., Strong M., Huang Z. Q. & Beckman J. S. (1996) Antibodies that recognize nitrotyrosine. Meth. Enzymol. 269, 201209.